Topic: Biobot Surveillance

BioBot Analytics co-founder Newsha Ghaeli describes the company's technology for analyzing sewage to create a global human health database. Originally focused on the opioid epidemic, the system can geolocate drug use and infectious diseases down to specific neighborhoods or buildings. The hosts compare the company's pitch to the Theranos scandal and raise significant privacy concerns regarding the tracking of pharmaceutical and illicit drug consumption.